Morepen Laboratories Limited — Important, 30-06-2025: General Updates

Morepen Laboratories has announced a board meeting to approve the financial results for the quarter and half-year. The company subscribed to 2 lakh equity shares in its subsidiary Morepen Medipath Limited’s fresh issue, reducing its holding from 80% to 60%. Meanwhile, promoter group’s stake in the subsidiary increased from 20% to 40%. This restructuring supports Morepen’s strategic focus on its home health business through the subsidiary, potentially unlocking value and driving growth in this segment.